Skip to main navigation
Skip to search
Skip to main content
Fujita Health University Home
English
日本語
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Oncogenic activation of the ret protooncogene in thyroid cancer
M. Takahashi
Research output
:
Contribution to journal
›
Review article
›
peer-review
46
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oncogenic activation of the ret protooncogene in thyroid cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cell Surface
25%
Clinical Feature
25%
Cysteine
25%
Disulfide
25%
Germline Mutation
25%
Medullary Carcinoma
25%
Multiple Endocrine Neoplasia
100%
Multiple Endocrine Neoplasia Type 2a
25%
Multiple Endocrine Neoplasia Type 2b
25%
Papillary Carcinoma
25%
Papillary Thyroid Cancer
50%
Pheochromocytoma
25%
Point Mutation
25%
Protein Ret
50%
Protein Tyrosine Kinase
50%
Proto Oncogene
100%
Radiation Exposure
25%
Somatics
25%
Thyroid Cancer
100%
Thyroid Medullary Carcinoma
50%
Thyroid Tumor
25%
Keyphrases
Cell Surface
16%
Chernobyl Accident
16%
Clinical Features
16%
Cysteine Residues
16%
Dimerization
33%
Disulfide
16%
Extracellular Domain
16%
Germline mutation
16%
Medullary Carcinoma
16%
Medullary Thyroid Carcinoma
33%
Multiple Endocrine Neoplasia Type 2 (MEN2)
100%
Oncogene
100%
Papillary Carcinoma
16%
Papillary Thyroid Carcinoma
33%
Pheochromocytoma
16%
Radiation Exposure
16%
Single-point mutation
16%
Somatic Rearrangement
16%
Thyroid Cancer
100%
Thyroid Tumor
16%
Tyrosine Kinase
33%
Tyrosine Kinase Domain
16%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Feature
25%
Cysteine
25%
Disulfide
25%
Medullary Carcinoma
25%
Multiple Endocrine Neoplasia
100%
Multiple Endocrine Neoplasia Type 2a
25%
Multiple Endocrine Neoplasia Type 2b
25%
Papillary Carcinoma
25%
Pheochromocytoma
25%
Protein Ret
50%
Protein Tyrosine Kinase
50%
Radiation Exposure
25%
Thyroid Cancer
100%
Thyroid Medullary Carcinoma
50%
Thyroid Papillary Carcinoma
50%
Thyroid Tumor
25%